Question to the Department of Health and Social Care:

To ask Her Majesty's Government what steps they are taking to ensure that NHS Trusts are equipped with the resources needed to (1) diagnose, and (2) treat, hemochromatosis.

Genomic testing for haemochromatosis is available through the NHS Genomic Medicine Service for patients in England showing unexplained iron overload suggestive of hereditary haemochromatosis. This testing is delivered via NHS Genomic Laboratory Hubs (GLHs), which ensures that testing is available for all eligible patients in England. Any clinician who suspects haemochromatosis can order this testing via the local GLH.

The National Institute for Health and Care Excellence is developing an evidence-based guideline to define high quality care for haemochromatosis and reduce variation in practice. Following the publication of this guideline, the National Health Service will review service provision to implement any treatment pathways recommended.